My primary focus is applying Brillouin elastography – a noninvasive, stiffness-specific spectroscopic technique for differentiation of melanoma from benign pigmented skin lesions. I envision this optical methodology being used in the future in both clinical setting to diagnose disease, as well as in a laboratory to evaluate the cancerous cells’ response to treatment.